Clinical Trial Update: Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II Clinical Study [Phase 2]

View source ↗

Summary

Phase II randomized study evaluating sintilimab with or without radiotherapy in recurrent or stage IV non-small cell lung cancer after platinum-based chemothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: Shanghai Cancer Hospital, China | Conditions: Lung Neoplasms | Phase 2 | Status: UNKNOWN